In the dynamic world of capital markets, an Initial Public Offering (IPO) always captures investor attention. It's a chance to invest in companies poised for growth, and understanding the nuances is key to making informed decisions. Today, we turn our spotlight to Cryogenic OGS Limited, a specialist in industrial measurement and filtration equipment, as it prepares to embark on its journey as a publicly listed entity.
Let's unravel the details of this upcoming SME IPO, examining its business strengths, financial health, and what it brings to the market.
Established in September 1997, Cryogenic OGS Limited specializes in the manufacturing and assembly of high-quality measurement and filtration equipment. Their sophisticated solutions cater to critical sectors like oil, gas, chemicals, and other fluid-related industries. The company's core strength lies in providing innovative and tailored services, ensuring precise measurement and efficient system operations for their diverse clientele.
With a manufacturing unit strategically located in Vadodara, Gujarat, spanning 8300 square meters, Cryogenic OGS demonstrates a commitment to integrated design, process engineering, and manufacturing capabilities, including fabrication, assembly, and rigorous testing.
The Cryogenic OGS IPO is a book-built issue, entirely composed of a fresh issuance of shares. Here's a quick overview of its structure:
| IPO Aspect | Details |
|---|---|
| Issue Type | SME Book Built Issue |
| Total Issue Size | 37,80,000 Equity Shares (aggregating up to ₹17.77 Cr) |
| Issue Price Band | ₹44 to ₹47 per share |
| Face Value | ₹10 per share |
| Listing At | BSE SME |
| Market Capitalization | ₹67.12 Cr (Post-IPO) |
Staying on top of the IPO timeline is crucial for potential investors. Here's a tentative schedule:
Investors can apply for shares in multiples of 3,000 shares. The minimum and maximum investment details for various investor categories are outlined below:
| Investor Category | Minimum Lot Size | Minimum Shares | Minimum Amount (Approx) |
|---|---|---|---|
| Retail Investor | 1 Lot | 3,000 shares | ₹1,41,000 |
| HNI (High Net Worth Individual) | 2 Lots | 6,000 shares | ₹2,82,000 |
It is often advised for investors to bid at the cut-off price to potentially mitigate risks associated with oversubscription.
A significant portion of the IPO is allocated to Anchor Investors, signaling institutional confidence in the company. Cryogenic OGS IPO successfully raised ₹5.05 crore from anchor investors on July 2, 2025.
The shares offered are distributed across various investor categories as follows:
| Investor Category | Shares Offered | Percentage (%) |
|---|---|---|
| Market Maker | 1,89,000 | 5.00% |
| Qualified Institutional Buyers (QIB) | 17,91,000 | 47.38% |
| - Anchor Investors | 10,74,000 | 28.41% |
| - QIB (Excluding Anchor) | 7,17,000 | 18.97% |
| Non-Institutional Investors (NII/HNI) | 5,40,000 | 14.29% |
| Retail Individual Investors (RII) | 12,60,000 | 33.33% |
| Total Shares Offered | 37,80,000 | 100.00% |
A company's financial performance is a cornerstone for investment analysis. Cryogenic OGS Limited has demonstrated consistent growth in its key financial metrics.
| Financial Metric | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|
| Assets | 33.85 | 28.35 | 24.00 |
| Revenue | 33.79 | 25.67 | 22.71 |
| Profit After Tax (PAT) | 6.12 | 5.35 | 4.08 |
| EBITDA | 7.96 | 6.39 | 5.65 |
| Net Worth | 28.99 | 22.86 | 17.52 |
| Total Borrowing | 0.00 | 0.00 | 0.00 |
The company shows a healthy upward trend with revenue increasing by 32% and PAT rising by 15% between FY2024 and FY2025. Notably, the company maintains zero total borrowing, indicating a strong and debt-free balance sheet.
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 23.62% |
| Return on Capital Employed (ROCE) | 28.93% |
| Return on Net Worth (RoNW) | 21.12% |
| Profit After Tax (PAT) Margin | 18.61% |
| EBITDA Margin | 24.20% |
| Price to Book Value | 1.70 |
| Earnings Per Share (Pre IPO) | ₹5.83 |
| P/E Ratio (Pre IPO) | 8.06x |
| Earnings Per Share (Post IPO) | ₹4.29 |
| P/E Ratio (Post IPO) | 10.96x |
The leadership of Cryogenic OGS Limited is driven by its dedicated promoters:
Before the IPO, the promoters held 100% of the company's shares. Post-issue, with the fresh issuance of shares, their holding will be approximately 73.53%, reflecting a dilution aimed at raising capital for growth.
Cryogenic OGS Limited intends to utilize the net proceeds from this IPO primarily for two key objectives:
This fresh capital infusion is expected to support the company's operational scaling and strategic initiatives.
A comprehensive understanding of a company includes looking at its internal strengths and weaknesses, alongside external opportunities and threats.
To ensure a smooth IPO process, various entities play crucial roles:
For investors interested in participating, the process is streamlined:
Cryogenic OGS Limited presents an opportunity to invest in a niche player within the essential industrial equipment sector. Its consistent financial performance, debt-free status, and experienced management team are noteworthy strengths. The IPO aims to bolster its working capital, positioning the company for continued operational efficiency and future growth.
As with any investment, it's crucial to consider all aspects, including the sector-specific risks and the characteristics of an SME listing. Potential investors should conduct their own due diligence, assess the company's long-term prospects against their investment goals, and consider consulting with a financial advisor.
For Advertising Queries, reach us at contactus@publiclisting.in
IPO Data News and Insights
Made in India
A Product by Saubhagya Samridhi